Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care. (Q38184384)

From Wikidata

Revision as of 02:31, 20 November 2018 by Renamerr (talk | contribs) (‎Changed Ukrainian description: наукова стаття, опублікована в лютому 2014, #quickstatements)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on February 2014

Language	Label	Description	Also known as
English	Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.	scientific article published on February 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

author name string

John D Hainsworth

1

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

F Anthony Greco

2

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

publication date

1 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Virchows Archiv

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

464

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

393-402

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Switching benchmarks in cancer of unknown primary: from autopsy to microarray

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Multiclass cancer diagnosis using tumor gene expression signatures

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Elucidation of a protein signature discriminating six common types of adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Feature selection and molecular classification of cancer using genetic programming

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Validation and Reproducibility of a Microarray-Based Gene Expression Test for Tumor Identification in Formalin-Fixed, Paraffin-Embedded Specimens

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

A second-generation microRNA-based assay for diagnosing tumor tissue origin

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Use of tumour marker immunoreactivity to identify primary site of metastatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Pathologic evaluation of unknown primary cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Diagnostic and therapeutic management of cancer of an unknown primary

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Diagnostic strategies for unknown primary cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Comparison of histopathological and gene expression-based typing of cancer of unknown primary.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Molecular profiling for druggable genetic abnormalities in carcinoma of unknown primary

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

MET mutations in cancers of unknown primary origin (CUPs).

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

21 January 2018

Identifiers

10.1007/S00428-014-1545-2

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38184384&oldid=794162606"